Our Products

Help Shape Patient Care Worldwide

As a leading innovation-driven organisation, Lilly is developing a growing portfolio of pharmaceutical products focused on meeting some of the world's most urgent medical needs in the fields of Cardiovascular, Diabetes, Men's health, Musculoskeletal, Neuroscience and Oncology.

Australian laws and regulations limit the amount of product information that we can provide to the general public via our website. We encourage patients wishing to obtain more detailed information on our products to speak to their healthcare professional.

The product information on this website is intended for Australian residents, if you're after our New Zealand Products page please click here.

 

  Cardiovascular Patients Healthcare Providers
  Adcirca® (tadalafil)
  Effient® (prasugrel)
   
  Dermatology
  Taltz ® (ixekizumab)
   
  Diabetes Patients Healthcare Providers
  Humalog® / Humalog Mix25 / Humalog Mix50 (insulin lispro) cartridges
  Humalog® / Humalog Mix25 / Humalog Mix50 (insulin lispro) Kwikpen
  Humalog® / Humalog Mix25 / Humalog Mix50 (insulin lispro) vials
  Humulin® (biosynthetic human insulin) cartridges
  Humulin® (biosynthetic human insulin) vials
   
  Diabetes – In alliance with Boehringer Ingelheim Patients Healthcare Providers
  Jardiance®* (empagliflozin)
  Trajenta®* (linagliptin)
  Trajentamet®* (linagliptin and metformin hydrochloride)
  * A licensed trademark of Boehringer Ingelheim    
   
  Men's Health Patients Healthcare Providers
  Axiron® (testosterone)
  Cialis® (tadalafil)
   
  Musculoskeletal Patients Healthcare Providers
  Evifyne® (raloxifene hydrochloride)
  Evista® (raloxifene hydrochloride)
  Forteo® (teriparatide of recombinant DNA origin)
  Humatrope® (somatropin)
   
  Neuroscience Patients Healthcare Providers
  Andepra® (duloxetine hydrochloride)
  Cymbalta® (duloxetine hydrochloride)
  Lanzek® (olanzapine) - Tablets and Wafers
  Prozac® (fluoxetine hydrochloride)
  Strattera® (atomoxetine hydrochloride)
  Zyprexa® (olanzapine) - Tablets and Wafers
  Zyprexa® IM (olanzapine) - Injection
  Zyprexa® Relprevv (olanzapine) long acting injectable
   
  Oncology Patients Healthcare Providers
  Alimta® (pemetrexed)
  Cyramza® (ramucirumab)

The Australian Therapeutic Goods Association (TGA) regularly issues safety alerts about counterfeit medicines that may have been unknowingly purchased by consumers via the internet or overseas. Click here to find out more.